Cargando…

Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients

Rheumatoid arthritis (RA) has a negative impact on bone that is partly mediated by anti-citrullinated proteins antibodies (ACPA). These antibodies are associated with erosions, and with juxta-articular and systemic bone loss. Other RA autoantibodies, the anti-carbamylated protein antibodies (anti-Ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regueiro, Cristina, Ortiz, Ana M., Boveda, Maria Dolores, Castañeda, Santos, Gonzalez-Alvaro, Isidoro, Gonzalez, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097678/ https://www.ncbi.nlm.nih.gov/pubmed/30118518 http://dx.doi.org/10.1371/journal.pone.0202583

Ejemplares similares

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
por: Regueiro, Cristina, et al.
Publicado: (2021)

Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies
por: Montes, Ariana, et al.
Publicado: (2016)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Regueiro, Cristina, et al.
Publicado: (2017)

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients
por: Llorente, Irene, et al.
Publicado: (2017)

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients
por: Vidal-Bralo, Laura, et al.
Publicado: (2017)

Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
por: Castañeda, Santos, et al.
Publicado: (2017)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
por: O’Neil, Liam J., et al.
Publicado: (2021)

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies
por: Nakabo, Shuichiro, et al.
Publicado: (2017)

Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
por: Pruijn, Ger J. M.
Publicado: (2015)

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
por: Shi, Jing, et al.
Publicado: (2015)

Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis
por: Li, Liubing, et al.
Publicado: (2016)

Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor
por: Othman, Maizatul A., et al.
Publicado: (2017)

Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
por: Spinelli, Francesca Romana, et al.
Publicado: (2017)

The effect of carbamylation on the functionality of high-density lipoprotein
por: Holzer, Michael, et al.
Publicado: (2009)

A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
por: Ibañez, Monica, et al.
Publicado: (2010)

Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis
por: Verheul, Marije K., et al.
Publicado: (2017)

Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
por: Spinelli, Francesca Romana, et al.
Publicado: (2017)

Anti-carbamylated protein antibodies in systemic sclerosis
por: Liem, Sophie I. E., et al.
Publicado: (2023)

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
por: Llorente, Irene, et al.
Publicado: (2020)

Antibodies Specific for Carbamylated Proteins Precede the Onset of Clinical Symptoms in Mice with Collagen Induced Arthritis
por: Stoop, Jeroen N., et al.
Publicado: (2014)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
por: van Delft, Myrthe A. M., et al.
Publicado: (2017)

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis
por: Castellanos-Moreira, Raul, et al.
Publicado: (2020)

Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis
por: Ricchiuti, Vincent, et al.
Publicado: (2022)

Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis
por: O’Neil, Liam J., et al.
Publicado: (2020)

Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
por: Chen, Zhongli, et al.
Publicado: (2020)

Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients
por: Lenglet, Aurelie, et al.
Publicado: (2023)

Anti-Citrullinated Protein Antibody Titers Are Independently Modulated by Both Disease Activity and Conventional or Biologic Anti-Rheumatic Drugs
por: Uriarte Ecenarro, Miren, et al.
Publicado: (2022)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

Complete Androgen Insensitivity and Decreased Bone Mineral Density
por: Bauer, Elizabeth M, et al.
Publicado: (2021)

Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies
por: Rodriguez-Martínez, Lorena, et al.
Publicado: (2020)

Carbamylated lipoproteins in diabetes
por: Denimal, Damien
Publicado: (2023)

Sex differences in frailty and its association with low bone mineral density in rheumatoid arthritis
por: Wysham, Katherine D., et al.
Publicado: (2020)

Evalution of In Vitro Effect of Flavonoids on Human Low-Density Lipoprotein Carbamylation
por: Ghaffari, Mohammad Ali, et al.
Publicado: (2010)

Bone mineral density in patients with Juvenile Rheumatoid Arthritis
por: Zhizho, Ye, et al.
Publicado: (2008)

Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation
por: Spinelli, Francesca Romana, et al.
Publicado: (2016)

Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis
por: Ospelt, Caroline, et al.
Publicado: (2017)

Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
por: Brink, Mikael, et al.
Publicado: (2016)

Hyaluronidase 1 deficiency decreases bone mineral density in mice
por: Puissant, Emeline, et al.
Publicado: (2022)

Protein Carbamylation and Cardiovascular Disease
por: Verbrugge, Frederik H., et al.
Publicado: (2015)

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
por: Wu, Chao-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6fl46141leta3med00j5rel417